ENGN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 13.70%

Insider Buying (Last 12 Months): $2,651,102.90

Insider Selling (Last 12 Months): $786,480.75

enGene Insider Trading History Chart

enGene Share Price & Price History

^$4.00

+0.30 (1.20%)

As of 04/11/2025 05:00 PM ET

Days: 30 | 90 | 365

enGene Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/7/2024	Growth Opportunities F Forbion	Major Shareholder	Buy	11,844	$6.55	$77,578.20	2,469,833
10/4/2024	Growth Opportunities F Forbion	Major Shareholder	Buy	5,997	$6.54	$39,220.38	2,457,989
10/2/2024	Growth Opportunities F Forbion	Major Shareholder	Buy	10,153	$6.37	$64,674.61	2,446,223
9/30/2024	Growth Opportunities F Forbion	Major Shareholder	Buy	341,332	$6.34	$2,164,044.88	2,400,791
9/27/2024	Growth Opportunities F Forbion	Major Shareholder	Buy	41,639	$5.97	$248,584.83	2,059,459
9/27/2024	Ronald Harold Wilfred Cooper	CEO	Buy	10,000	$5.70	$57,000.00	10,000
4/22/2024	De Solidarite Des Travai Fonds	Major Shareholder	Sell	47,854	$15.00	$717,810.00	3,036,153
4/18/2024	De Solidarite Des Travai Fonds	Major Shareholder	Sell	4,575	$15.01	$68,670.75	3,084,107
12/29/2023	Growth Opportunities F Forbion	Major Shareholder	Buy	10,020	$9.06	$90,781.20	2,017,820
12/27/2023	Growth Opportunities F Forbion	Major Shareholder	Buy	2,750	$7.17	$19,717.50	2,002,750

See Full Table

SEC Filings (Institutional Ownership Changes) for enGene (NASDAQ:ENGN)

64.16% of enGene stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

enGene Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/19/2025	Toronto Dominion Bank	14,537	$97K	0.0%	N/A	0.033%
2/17/2025	VR Adviser LLC	5,046,414	$33.56M	2.3%	+41.5%	11.412%
2/17/2025	Vestal Point Capital LP	370,000	$2.46M	0.1%	N/A	0.837%
2/17/2025	Two Sigma Investments LP	35,866	$0.24M	0.0%	-9.5%	0.081%
2/17/2025	Toronto Dominion Bank	14,537	$97K	0.0%	N/A	0.033%
2/17/2025	Sphera Funds Management LTD.	560,000	$3.72M	0.7%	N/A	1.266%
2/17/2025	Point72 Asset Management L.P.	1,224,797	$8.15M	0.0%	+84.7%	2.770%
2/17/2025	Orbimed Advisors LLC	920,339	$6.12M	0.1%	N/A	2.081%
2/17/2025	Omega Fund Management LLC	526,357	$3.50M	2.9%	-51.1%	1.190%
2/17/2025	Fcpm Iii Services B.V.	9,632,561	$64.06M	10.9%	+11.0%	21.783%
2/17/2025	Deep Track Capital LP	4,557,575	$30.31M	1.1%	+74.8%	10.307%
2/17/2025	Corton Capital Inc.	23,601	$0.16M	0.1%	N/A	0.053%
2/17/2025	Cubist Systematic Strategies LLC	15,342	$0.10M	0.0%	+15.7%	0.035%
2/17/2025	BVF Inc. IL	2,106,037	$14.01M	0.5%	-6.4%	4.763%
2/14/2025	Jane Street Group LLC	14,038	$93K	0.0%	N/A	0.032%
2/14/2025	Schonfeld Strategic Advisors LLC	132,260	$0.88M	0.0%	-56.8%	0.299%
2/14/2025	Blue Owl Capital Holdings LP	3,159,975	$21.01M	5.0%	+3.3%	7.146%
2/14/2025	Adage Capital Partners GP L.L.C.	1,529,768	$10.17M	0.0%	-34.3%	3.459%
2/13/2025	Marshall Wace LLP	593,742	$3.95M	0.0%	-12.9%	1.343%
1/30/2025	Vontobel Holding Ltd.	10,417	$69K	0.0%	N/A	0.024%
11/27/2024	Franklin Resources Inc.	1,189,952	$7.85M	0.0%	+48.7%	2.691%
11/15/2024	Point72 Asset Management L.P.	663,000	$4.38M	0.0%	+1,410.3%	1.499%
11/4/2024	Wolverine Asset Management LLC	5,574	$37K	0.0%	N/A	0.013%
8/19/2024	Point72 Asset Management L.P.	43,900	$0.41M	0.0%	-76.0%	0.099%
8/16/2024	Perceptive Advisors LLC	800,000	$7.54M	0.2%	-19.9%	1.811%
8/15/2024	Blue Owl Capital Holdings LP	2,449,827	$23.10M	6.4%	-0.5%	5.547%
8/14/2024	Marshall Wace LLP	764,645	$7.21M	0.0%	-4.4%	1.731%
8/14/2024	Logos Global Management LP	1,200,000	$11.32M	0.9%	+50.0%	2.717%
8/13/2024	SR One Capital Management LP	500,000	$4.72M	1.5%	N/A	1.132%
5/16/2024	Janus Henderson Group PLC	1,000,000	$17.10M	0.0%	N/A	2.295%
5/15/2024	Altitude Crest Partners Inc.	120,289	$2.04M	0.9%	N/A	0.276%
3/7/2024	Fcpm Iii Services B.V.	8,677,951	$80.10M	23.8%	N/A	37.408%
2/15/2024	Omega Fund Management LLC	1,131,175	$10.44M	8.5%	N/A	4.876%
2/15/2024	BVF Inc. IL	2,251,037	$20.78M	0.5%	N/A	9.703%
2/7/2024	Vivo Capital LLC	678,705	$6.26M	0.5%	N/A	2.925%

Data available starting January 2016

See Full Table

enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.

Today's Range

Now: $4.00

$3.82

$4.02

50 Day Range

MA: $5.31

$4.00

$6.90

52 Week Range

Now: $4.00

$3.50

$16.62

Volume

37,230 shs

Average Volume

131,311 shs

Market Capitalization

$203.91 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of enGene?: enGene's top insider investors include:
De Solidarite Des Travai Fonds (Major Shareholder)
Growth Opportunities F Forbion (Major Shareholder)
Ronald Harold Wilfred Cooper (CEO)
Learn More about top insider investors at enGene.